AMC-1

N/A

Report date: 2025/06/11 10:53:23
NME

Base Information

Drug NameAMC-1
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionHistone-lysine N-methyltransferase EHMT2 inhibitorsNeuroprotectantsEuchromatic Histone Lysine Methyltransferase 1 inhibitors
TargetsHistone-lysine N-methyltransferase EHMT2Euchromatic Histone Lysine Methyltransferase 1
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversitat De Barcelona
China Registration ClassN/A

Develop Information

Active CompaniesInstituto de Salud Carlos IIIUniversitat De BarcelonaUniversity Of Santiago De Compostela
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A